O'Keefe Stevens Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.48M | Buy |
102,304
+4,245
| +4% | +$103K | 0.7% | 26 |
|
2025
Q1 | $2.48M | Buy |
98,059
+2,181
| +2% | +$55.3K | 0.81% | 25 |
|
2024
Q4 | $2.54M | Buy |
95,878
+31,010
| +48% | +$823K | 0.79% | 26 |
|
2024
Q3 | $1.88M | Buy |
64,868
+12,567
| +24% | +$364K | 0.57% | 27 |
|
2024
Q2 | $1.46M | Buy |
52,301
+26,724
| +104% | +$748K | 0.49% | 28 |
|
2024
Q1 | $710K | Buy |
25,577
+10,143
| +66% | +$281K | 0.23% | 30 |
|
2023
Q4 | $444K | Buy |
15,434
+6,516
| +73% | +$188K | 0.18% | 34 |
|
2023
Q3 | $296K | Buy |
8,918
+813
| +10% | +$27K | 0.13% | 35 |
|
2023
Q2 | $297K | Buy |
8,105
+1,184
| +17% | +$43.4K | 0.13% | 36 |
|
2023
Q1 | $282K | Buy |
6,921
+846
| +14% | +$34.5K | 0.14% | 34 |
|
2022
Q4 | $311K | Hold |
6,075
| – | – | 0.18% | 33 |
|
2022
Q3 | $266K | Hold |
6,075
| – | – | 0.18% | 32 |
|
2022
Q2 | $319K | Hold |
6,075
| – | – | 0.2% | 32 |
|
2022
Q1 | $315K | Sell |
6,075
-100
| -2% | -$5.19K | 0.15% | 32 |
|
2021
Q4 | $365K | Hold |
6,175
| – | – | 0.17% | 32 |
|
2021
Q3 | $266K | Hold |
6,175
| – | – | 0.15% | 36 |
|
2021
Q2 | $242K | Hold |
6,175
| – | – | 0.13% | 35 |
|
2021
Q1 | $222K | Hold |
6,175
| – | – | 0.14% | 34 |
|
2020
Q4 | $227K | Sell |
6,175
-333
| -5% | -$12.2K | 0.16% | 37 |
|
2020
Q3 | $227K | Hold |
6,508
| – | – | 0.18% | 37 |
|
2020
Q2 | $202K | Buy |
+6,508
| New | +$202K | 0.17% | 36 |
|
2019
Q4 | $240K | Hold |
6,508
| – | – | 0.18% | 37 |
|
2019
Q3 | $222K | Hold |
6,508
| – | – | 0.17% | 39 |
|
2019
Q2 | $268K | Hold |
6,508
| – | – | 0.2% | 37 |
|
2019
Q1 | $262K | Hold |
6,508
| – | – | 0.2% | 35 |
|
2018
Q4 | $270K | Hold |
6,508
| – | – | 0.24% | 34 |
|
2018
Q3 | $272K | Hold |
6,508
| – | – | 0.19% | 35 |
|
2018
Q2 | $224K | Sell |
6,508
-159
| -2% | -$5.47K | 0.18% | 36 |
|
2018
Q1 | $224K | Buy |
6,667
+633
| +10% | +$21.3K | 0.2% | 43 |
|
2017
Q4 | $207K | Buy |
+6,034
| New | +$207K | 0.19% | 42 |
|